Surgical damage to the lymphatic system promotes tumor growth via impaired adaptive immune response

Journal of Dermatological Science

Volumn 90, Issue 1, 2018, Pages 46-51

  Nakamura, Yoshiyuki ^a   Fujisawa, Yasuhiro ^a   Okiyama, Naoko ^a   Watanabe, Rei ^a   Tanaka, Ryota ^a   Ishitsuka, Yosuke ^a   Tahara, Hideaki ^b   Fujimoto, Manabu ^a  

^a UNIVERSITY OF TSUKUBA   (Japan)

^b UNIVERSITY OF TOKYO   (Japan)

Author keywords

Adaptive immunity; Lymph node dissection; Melanoma; Skin flap; Tumor growh

Indexed keywords

ADAPTIVE IMMUNITY; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL INFILTRATION; CONTROLLED STUDY; CYTOTOXICITY; LYMPH NODE DISSECTION; LYMPHATIC SYSTEM; MELANOMA; MOUSE; NONHUMAN; PRIORITY JOURNAL; SKIN FLAP; TUMOR CELL; TUMOR GROWTH; ANIMAL; BAGG ALBINO MOUSE; BIOPSY; C57BL MOUSE; DISEASE EXACERBATION; DRUG SCREENING; HUMAN; IMMUNOLOGY; LYMPH NODE; LYMPH NODE METASTASIS; LYMPH VESSEL; PATHOLOGY; SKIN TUMOR; SURGERY; T LYMPHOCYTE; TUMOR CELL LINE;

ADAPTIVE IMMUNITY; ANIMALS; BIOPSY; CELL LINE, TUMOR; CYTOTOXICITY, IMMUNOLOGIC; DISEASE PROGRESSION; HUMANS; LYMPH NODE EXCISION; LYMPH NODES; LYMPHATIC METASTASIS; LYMPHATIC VESSELS; MELANOMA; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; SKIN NEOPLASMS; T-LYMPHOCYTES; XENOGRAFT MODEL ANTITUMOR ASSAYS;

EID: 85040534128     PISSN: 09231811     EISSN: 1873569X     Source Type: Journal    
DOI: 10.1016/j.jdermsci.2017.12.016     Document Type: Article

References (15)

1. Postow, M.A., Callahan, M.K., Wolchok, J.D., Immune checkpoint blockade in cancer therapy. J. Clin. Oncol. 33 (2015), 1974–1982.
2. Prasad, V., Kaestner, V., Nivolumab and pembrolizumab. Monoclonal antibodies against programmed cell death-1 (PD-1) that are interchangeable. Semin. Oncol. 44 (2017), 132–135.
3. Huppa, J.B., Davis, M.M., The interdisciplinary science of T-cell recognition. Adv. Immunol. 119 (2013), 1–50.
4. Morton, D.L., Thompson, J.F., Cochran, A.J., Mozzillo, N., Elashoff, R., Essner, R., et al. Sentinel-node biopsy or nodal observation in melanoma. N. Engl. J. Med. 355 (2006), 1307–1317.
5. Easson, A.M., Rotstein, L.E., McCready, D.R., Lymph node assessment in melanoma. J. Surg. Oncol. 99 (2009), 176–185.
6. Hanks, J.E., Moyer, J.S., Brenner, M.J., Reconstruction of cheek defects secondary to Mohs microsurgery or wide local excision. Facial Plast. Surg. Clin. N. Am. 25 (2017), 443–461.
7. Bhatt, Y.C., Singh, S., Doshi, P., Vaghani, S.G., Reverse peroneal artery flap for large heel and sole defects: a reliable coverage. World J. Plast. Surg. 6 (2017), 212–219.
8. Stachura, J., Wachowska, M., Kilarski, W.W., Guc, E., Golab, J., Muchowicz, A., The dual role of tumor lymphatic vessels in dissemination of metastases and immune response development. Oncoimmunology, 5, 2016, e1182278.
9. Chaurio, R.A., Munoz, L.E., Maueroder, C., Janko, C., Harrer, T., Furnrohr, B.G., et al. The progression of cell death affects the rejection of allogeneic tumors in immune-competent mice – implications for cancer therapy. Front. Immunol., 5, 2014, 560.
10. Wang, J., Saffold, S., Cao, X., Krauss, J., Chen, W., Eliciting T cell immunity against poorly immunogenic tumors by immunization with dendritic cell-tumor fusion vaccines. J. Immunol. 161 (1998), 5516–5524.
11. Faries, M.B., Thompson, J.F., Cochran, A.J., Andtbacka, R.H., Mozzillo, N., Zager, J.S., et al. Completion dissection or observation for sentinel-node metastasis in melanoma. N. Engl. J. Med. 376 (2017), 2211–2222.
12. Hudson, D.A., Achieving an optimal cosmetic result with excision of lesions on the face. Ann. Plast. Surg. 68 (2012), 320–325.
13. Nghiem, P.T., Bhatia, S., Lipson, E.J., Kudchadkar, R.R., Miller, N.J., Annamalai, L., et al. PD-1 blockade with pembrolizumab in advanced merkel-cell carcinoma. N. Engl. J. Med. 374 (2016), 2542–2552.
14. Palyca, P., Koshenkov, V.P., Mehnert, J.M., Developments in the treatment of locally advanced and metastatic squamous cell carcinoma of the skin: a rising unmet need. Am. Soc. Clin. Oncol. Educ. Book, 2014, e397–404.
15. Weber, J., Mandala, M., Del Vecchio, M., Gogas, H.J., Arance, A.M., Cowey, C.L., et al. Adjuvant nivolumab versus ipilimumab in resected stage III or IV melanoma. N. Engl. J. Med. 377 (2017), 1824–1835.